Ligand Pharmaceuticals Incorporated
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 7 name spellings.
20
Ending by 2030
Mar 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 18, 2026
- 2 fees due Feb 13 to 15, 2027 · next Feb 13
- 2 fees due Mar 22 to 24, 2027 · next Mar 22
- 4 fees due Apr 3 to 22, 2027 · next Apr 3
- 1 fee due May 14, 2027The maintenance fee for Topical Compositions and Methods of Using the Same (US 11,813,284) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Jun 10, 2027The maintenance fee for Topical Compositions (US 10,500,220) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
- 2 fees due Jul 2 to 19, 2027 · next Jul 2
- 2 fees due Aug 23, 2027
- 2 fees due Sep 22 to 30, 2027 · next Sep 22
- 1 fee due Oct 30, 2027The maintenance fee for Acetal compounds and therapeutic uses thereof (US 11,970,482) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
- 1 fee due Nov 3, 2027The maintenance fee for Nucleotide prodrug compounds and use (US 9,326,991) comes due Nov 3, 2027. Unpaid by May 3, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,791,127 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles In force · Medium confidence | In force | Medium confidence | |
| US 8,747,896 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles In force · Medium confidence | In force | Medium confidence | |
| US 8,211,466 | Mucosal Bioadhesive Slow Release Carrier for Delivering Active Principles In force · Medium confidence | In force | Medium confidence | |
| US 8,193,357 | Androgen receptor modulator compounds In force · From the USPTO record | In force | From the USPTO record | |
| US 8,354,446 | Selective androgen receptor modulators (SARMs) and uses thereof In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 8,748,633 | Selective androgen receptor modulators (SARMs) and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,139,520 | Selective androgen receptor modulators (SARMs) and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,675,583 | Selective androgen receptor modulators (SARMS) and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,106,500 | Selective androgen receptor modulators (SARMs) and uses thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 10,730,831 | Selective androgen receptor modulators (SARMs) and uses thereof In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 85: 2 patents in force now held by others · 85 lapsed for an unpaid fee · 73 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 2 abandoned · 18 no status recorded